Track topics on Twitter Track topics that are important to you
Nationwide Fund Advisors decreased its position in shares of Achillion Pharmaceuticals, Inc. by 6.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission . The institutional investor owned 81,140 shares of the biopharmaceutical company's stock after selling 5,139 shares during the period.NEXT ARTICLE
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...